tert-Butyl (2-(4-bromophenyl)-5,8-dioxaspiro[3.4]octan-2-yl)carbamate

Catalog No. :
ACHMMQ854
CAS No. :
1199557-05-5
Molecular Formula :
C17H22BrNO4
Molecular Weight :
384.27

IUPAC Name:tert-butyl (2-(4-bromophenyl)-5,8-dioxaspiro[3.4]octan-2-yl)carbamate

tert-Butyl (2-(4-bromophenyl)-5,8-dioxaspiro[3.4]octan-2-yl)carbamate structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
1g95%$467.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Nametert-Butyl (2-(4-bromophenyl)-5,8-dioxaspiro[3.4]octan-2-yl)carbamate
IUPAC Nametert-butyl (2-(4-bromophenyl)-5,8-dioxaspiro[3.4]octan-2-yl)carbamate
MDL No.MFCD21648238
Molecular FormulaC17H22BrNO4
Molecular Weight384.27
SMILESO=C(OC(C)(C)C)NC1(C2=CC=C(Br)C=C2)CC3(OCCO3)C1
InChI KeyLYIRVIKBEJEIMX-UHFFFAOYSA-N
Synonymtert-butyl 2-(4-broMophenyl)-5,8-dioxaspiro[3.4]octan-2-ylcarbaMate;Carbamic acid, N-[2-(4-bromophenyl)-5,8-dioxaspiro[3.4]oct-2-yl]-, 1,1-dimethylethyl ester
CAS No.1199557-05-5

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P301+P312-P302+P352-P304+P340-P305+P351+P338-P330-P332+P313-P337+P313-P362-P403+P233-P405-P501

Synthetic Route by SureRoute

1. ACHMMQ854 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACFBPZ072 route compound structure diagram
    ACFBPZ07236809-75-3 In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACHMMQ854 route product structure diagram
    ACHMMQ8541199557-05-5
Inquiry

2. ACHMMQ854 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACHMMQ854 route product structure diagram
    ACHMMQ8541199557-05-5
Inquiry

Comments (0)